← All companies
CRISPR Therapeutics AG
CRSP - CIK 0001674416
Market cap$4.77 B
Rank#1422
SEC filings837
The table below shows CRISPR Therapeutics AG's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $347.56M | $298.26M | $389.48M | $211.88M | $923.03M | $1.17B |
| Short-term investments | $1.63B | $1.61B | $1.30B | $1.60B | $1.46B | $521.71M |
| Receivables | $0.00 | $25.00M | $200.00M | $0.00 | $305.00K | $144.00K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.